Stay updated on Bispecific Antibody MCLA-158 Clinical Trial
Sign up to get notified when there's something new on the Bispecific Antibody MCLA-158 Clinical Trial page.

Latest updates to the Bispecific Antibody MCLA-158 Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page's Locations section was updated to include a consolidated list of states. Individual state location pages were removed, and the revision updated to v3.3.3.SummaryDifference0.8%

- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.2.0 was removed, reflecting a page version metadata update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check40 days agoChange DetectedRemoved the government funding lapse notice; the study details content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check62 days agoChange DetectedNo meaningful content changes detected between the two screenshots; no additions or deletions affecting core content, navigation, or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check83 days agoChange Detected- Added a government funding/operating status notice and a link to cc.nih.gov and opm.gov. - Updated version to v3.2.0. - Removed the resource: Genetic and Rare Diseases Information Center resources: Carcinoma of esophagus (v3.1.0).SummaryDifference2%

- Check91 days agoChange DetectedUpdated contact details and new software revision (v3.1.0) replace an old disease term and older revision (v3.0.2).SummaryDifference0.2%

Stay in the know with updates to Bispecific Antibody MCLA-158 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Bispecific Antibody MCLA-158 Clinical Trial page.